More articles from Preclinical Probes for Oncology

You have access
Diagnostic efficacy of 68Ga-DOTAGA-Duramycin for detection of doxorubicin induced organ toxicity in Wistar rats
Gurvinder Gill, Somit Pandey, Imraan Rather, Rakhee Vatsa, Karan Tanwar, Amanjit Bal, Gaurav Prakash, Ashwani Sood, Bhagwant Mittal and JAYA SHUKLA

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 2892;
You have access
Detecting Doxorubicin Induced Surface Expression of Calreticulin Using a 68Ga-Radiolabeled Peptide
Maxwell Ducharme, Odalyz Montes, J. Bart Rose, Benjamin Larimer and Suzanne Lapi

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 2870;
You have access
Arylhalide Albumin Binder-Mediated Extended Circulation Imparts Longer Tumor Retention of [177Lu]-LLP2A Conjugates in VLA-4 Expressing Murine Melanoma
Aron Roxin, Chengcheng Zhang, Jutta Zeisler, Nadine Colpo, Xinchi Hou, Carlos Uribe, Zhengxing Zhang, Kuo-Shyan Lin and Francois Benard

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 2863;
You have access
PET imaging of tryptophan metabolism in a neurofibromatosis type 1 animal model
Xuyi Yue, Sigrid Langhans, Thomas Shaffer, Vinay Kandula, Gurcharanjeet Kaur, Heidi Kecskemethy, Lauren Averill and Rahul Nikam

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 2867;
You have access
In-vitro stability and labelling yield of 188Re-N-DEDC lipiodol using indigenously produced freeze-dried kits in trans-arterial radionuclide therapy (TART) for treatment of hepatocellular carcinoma (HCC)
Naresh Kumar, Priyanka Gupta, Geetanjali Arora, Shivanand Gamanagatti, . Shalimar, Chandrasekhar Bal and Shamim Ahmed Shamim

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 2888;
You have access
Biodistribution and in-vivo stability of a pet tracer for lung perfusion imaging
Merline Babu, Sneha Mithun, Punita Bhardwaj, Meryl Maria Vilangattil, Kinnari Chitnis, Niha Nisar, Ashish Jha, Amit Nautiyal, Bhabani Mohanty, Pradip Chaudhari, Rakhee Vatsa, Mythili Kameswaran and VENKATESH RANGARAJAN

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 2886;
You have access
Development and initial evaluation of a fully human anti-nectin-4 antibody as theranostic probes for nectin-4 positive triple negative breast cancers
Hanan Babeker, Jessica Pougoue Ketchemen, Arun Sudarsun, Samitha Andrahendi, Florence Tikum, Anand Nambisan, Musharraf Khan, Fabrice Ngoh Njotu, Maruti Uppalapati and Humphrey Fonge

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 2865;
You have access
Comparative analyses of the biodistribution of 89Zr-labeled human serum albumin in the mouse and HET-CAM model
Colmar Hilbrig, Jessica Loeffler, Gabriel Fischer, Hendrik Herrmann, Christoph Solbach, Markus Huber-Lang, Volker Rasche, Ambros Beer and Gordon Winter

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 2887;
You have access
A new series of PSMA-targeting inhibitors for astatine-211 targeted radionuclide therapy of prostate cancer
Mohamed El Fakiri, Nawal Ayada, Christian Poulie, Marius Müller, Teodor Gamzov, Holger Jensen, Sture Lindegren, Andreas Ingemann, Andreas Kjaer, Ann-Christin Eder, Matthias Eder and Matthias Herth

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 2878;
You have access
A preliminary study on noninvasively imaging CAR T cells with PSMA-targeted PET
Xiangming Song, Xiaoying Lv, Yu Long, Yirui Zhang, Zhuoshuo Xu, Yongkang Gai, Dawei Jiang, Ping Lei and Xiaoli Lan

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 2874;

Main menu

User menu

Search

More articles from Preclinical Probes for Oncology

Pages